74 research-tied claims examined: 5 contradicted 5 overstated 7 context 50 supported 7 unverified
"and remember the capillaries, it represents 90 percent of your brain vasculature, all these tiny blood vessels." (said at 0:00:17)
No published record matching the specific claim that capillaries represent approximately 90 percent of the brain's vasculature was located; this does not prove the claim false.
"But again, we are talking about one-fourth of the population of the world having the APOE4 genotype, so one-fourth, there's heterozygous and homozygous people." (said at 0:14:50)
No published record matching the claim that approximately one-fourth (25%) of the world's population carries an APOE4 genotype was located among the retrieved sources; this does not prove the claim false.
"and you mentioned MFSD2A, which is one of the markers we are studying carefully because it's specific to the smallest blood vessels in the brain, so the capillaries, and that's where most of the pericytes are." (said at 0:25:26)
No published record matching the claim that the omega-3 transporter MFSD2A is specifically localized to the smallest blood vessels (capillaries) in the brain was located; this does not prove the claim false.
"And these processes will shorten because of the inflammation, and of course if the pericytes are shortening their processes, the flow will reduce." (said at 0:24:05)
No published record matching the claim that vascular inflammation causes brain pericytes to shorten their cellular processes and thereby reduce cerebral blood flow was located; this does not prove the claim false. While brain pericytes participate in neurovascular regulation, capillary constriction, and inflammatory signaling, a specific mechanism where inflammation-induced shortening or retraction of pericyte processes directly mediates reduced cerebral blood flow has not been demonstrated in the published literature.
"And, you know, as you mentioned, at least about a quarter of the population has one allele." (said at 1:02:07)
No published record matching the claim that approximately one quarter of the human population carries at least one APOE4 allele was located; this does not prove the claim false.
"because to give you an example here, maybe a third, even more, of the cohort of these patients that we follow, they don't have any hypertension, first of all. So it tells you that there's a big chunk of people that can move to small vessel disease" (said at 1:19:04)
No published record matching the specific proportion of patients without hypertension in the cited cerebral small vessel disease cohort was located; this does not prove the claim false. While hypertension is established as a major risk factor for cerebral small vessel disease (CSVD) and white matter hyperintensities, the exact proportion of normotensive individuals across specific longitudinal clinical cohorts varies across study cohorts and definitions.
"if you have early, like 30s, 40s—30s, 40s, if early hypertension, you will have a likelihood and more chance to develop cognitive decline quickly as compared to a normotensive person of the same age. And interestingly, they were showing also in the paper that if it's during your 70s, if I remember correctly, it doesn't impact your likelihood to develop dementia." (said at 1:20:08)
No published record matching the claim that hypertension onset specifically in the 30s and 40s leads to rapid cognitive decline while onset in the 70s has no impact on dementia risk was located; this does not prove the claim false.